Other: Interventional Clinical Trial for CCSVI in MS Patients

Agency: 
CIHR

This Funding Opportunity invites research teams to submit proposals for the conduct of a combined Phase I/II interventional clinical trial for CCSVI in multiple sclerosis patients. Working with the Scientific Expert Working Group, CIHR has identified select elements (some being very specific) that all applications will be required to incorporate into their proposed trial design. Those specific requirements for inclusion (or exclusion) are outlined as part of the application requirements below.

Deadline: 
February 29, 2012

Last updated January 17, 2012